Compensation 990

The Ovarian Cancer Research Fund Inc.

Fiscal year ending 2024. Filed on November 5, 2025.

45 Rockefeller Plaza 20th Floor
Square 2023
New York, New York 10111

The Ovarian Cancer Research Fund Inc. (EIN: 13-3806788), also known as Ovarian Cancer Research Alliance, has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, The Ovarian Cancer Research Fund Inc., a 501(c)(3) charitable organization, reported compensation for 8 out of 21 total employees. Among the employees shown here, the average compensation is $196,230. The highest compensated employee at The Ovarian Cancer Research Fund Inc. is Audra L Moran with fiscal year 2024 compensation of $358,239.

Revenue, expenses, and employee compensation

Revenue

$10,047,998

Expenses

$13,556,516

Employee compensation

$2,887,953
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

＋3.6%vs 2023
Audra L Moran
President and Chief Executive Officer
$358,239
$324,287 from orgNo related comp$33,952 other
＋3.9%vs 2023
Jonathan Zeidman
Chief Development Officer
$242,378
$189,019 from orgNo related comp$53,359 other
＋6.1%vs 2023
Sarah C Defeo
Chief Program Officer
$233,685
$166,391 from orgNo related comp$67,294 other
＋3.6%vs 2023
Tracy Moore
Vice President Support and Education
$184,979
$157,837 from orgNo related comp$27,142 other
＋5.4%vs 2023
Nicole Wargo
Vice President - Philanthropic Partner
$162,458
$126,274 from orgNo related comp$36,184 other
＋3.7%vs 2023
Chad Ramsey
Vice President, Policy
$148,954
$123,276 from orgNo related comp$25,678 other
New in 2024
Jessica Hughson Andrade
Senior Director, Strategic Alliance
$131,922
$108,675 from orgNo related comp$23,247 other
New in 2024
Brian Phair
Director, Donor Relations
$107,226
$102,012 from orgNo related comp$5,214 other

Non-Employee Board Members

Andrew Feuerstein, Esq
Director
Carol J Hamilton
Director
Caroline Hirsch
Director
Chris Newcomb
Director
Christopher Tilberis
Director
Dana L Mark, Esq
Director
Debra Birnbaum
Director
Dr Carmel J Cohen
Director
Elle Simone Scott
Director
Jeannette Chang
Director
John Orrico
Chair
John W Hansbury, Esq
Director

Contractors

New in 2024
Adc Strategic Communications
Communication
$213,604
New in 2024
Benjamin Austin
Marketing Consulting
$190,589
New in 2024
Amplifi
Mailing
$170,647
New in 2024
Cosgrove Accounting LLC
Accounting
$160,524
New in 2024
Color Health
Hereditary Testing Kits
$110,464

Mission Statement

OVARIAN CANCER RESEARCH ALLIANCE (OCRA) IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES.

Revisions to this organization profile

November 13, 2025:
Amended (originally filed November 14, 2024)2023 The Ovarian Cancer Research Fund Inc. 990 filed
November 5, 2025:
2024 The Ovarian Cancer Research Fund Inc. 990 filed
November 13, 2023:
2022 The Ovarian Cancer Research Fund Inc. 990 filed

Get an email when new compensation information is released for The Ovarian Cancer Research Fund Inc.

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →